Michael Rabinowitz Net Worth

The estimated Net Worth of Michael Rabinowitz is at least $828 Tysiąc dollars as of 3 January 2023. Mr Rabinowitz owns over 13,325 units of Oramed Pharmaceuticals, Inc stock worth over $300,220 and over the last 2 years he sold ORMP stock worth over $167,229. In addition, he makes $360,180 as Chief Commercial Officer at Oramed Pharmaceuticals, Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Rabinowitz ORMP stock SEC Form 4 insiders trading

Mr has made over 1 trades of the Oramed Pharmaceuticals, Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he sold 13,325 units of ORMP stock worth $167,229 on 3 January 2023.

The largest trade he's ever made was selling 13,325 units of Oramed Pharmaceuticals, Inc stock on 3 January 2023 worth over $167,229. On average, Mr trades about 6,663 units every 0 days since 2022. As of 3 January 2023 he still owns at least 126,143 units of Oramed Pharmaceuticals, Inc stock.

You can see the complete history of Mr Rabinowitz stock trades at the bottom of the page.

Mr. Michael Rabinowitz biography

Michael Rabinowitz is the Chief Commercial Officer at Oramed Pharmaceuticals, Inc.

What is the salary of Mr Rabinowitz?

As the Chief Commercial Officer of Oramed Pharmaceuticals, Inc, the total compensation of Mr Rabinowitz at Oramed Pharmaceuticals, Inc is $360,180. There are 6 executives at Oramed Pharmaceuticals, Inc getting paid more, with Nadav Kidron having the highest compensation of $1,551,100.

How old is Mr Rabinowitz?

Mr Rabinowitz is 56, he's been the Chief Commercial Officer of Oramed Pharmaceuticals, Inc since . There are 6 older and 8 younger executives at Oramed Pharmaceuticals, Inc. The oldest executive at Oramed Pharmaceuticals, Inc is Dr. Miriam Kidron Ph.D., 81, who is the Chief Scientific Officer & Director.

Insiders trading at Oramed Pharmaceuticals, Inc

Over the last 17 years, insiders at Oramed Pharmaceuticals, Inc have traded over $7,377,390 worth of Oramed Pharmaceuticals, Inc stock and bought 881,642 units worth $3,583,418 . The most active insiders traders include Miriam Kidron, Leonard Sank oraz Nadav Kidron. On average, Oramed Pharmaceuticals, Inc executives and independent directors trade stock every 111 days with the average trade being worth of $97,149. The most recent stock trade was executed by Arie Mayer on 3 April 2023, trading 8,809 units of ORMP stock currently worth $19,556.

What does Oramed Pharmaceuticals, Inc do?

oramed pharmaceuticals (nasdaqcm:ormp) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 trials under the usfda, the company is seeking to revolutionize the treatment of diabetes. read more: http://www.oramed.com/investors/corporate-presentation watch: https://www.youtube.com/watch?v=5qchxtdv9eg

Complete history of Mr Rabinowitz stock trades at Oramed Pharmaceuticals, Inc

Oramed Pharmaceuticals, Inc executives and stock owners

Oramed Pharmaceuticals, Inc executives and other stock owners filed with the SEC include:

• Nadav Kidron,
  President, Chief Executive Officer, Director
• Nadav Kidron Esq.,
  Pres, CEO & Exec. Director
• Miriam Kidron,
  Chief Scientific Officer, Director
• Joshua Hexter,
  Chief Operating and Business Officer
• Dr. Miriam Kidron Ph.D.,
  Chief Scientific Officer & Director
• Dr. Miriam Kidron,
  Chief Scientific Officer & Director
• Michael Rabinowitz,
  Chief Commercial Officer
• Joshua Hexter,
  Chief Operating & Bus. Officer
• David Silberman,
  CFO, Treasurer & Sec.
• Avraham Gabay,
  Chief Financial Officer, Treasurer, Secretary
• Kevin Rakin,
  Independent Chairman of the Board
• Leonard Sank,
  Independent Director
• Arie Mayer,
  Independent Director
• Xiaoming Gao,
  Independent Director
• Aviad Friedman,
  Independent Director
• Dr. Roy Eldor M.D., Ph.D.,
  Chief Medical Advisor & Member of the Scientific Advisory Board
• Daniel Aghion,
  Director
• Capital Management Lp Regal...,
  
• Xiaopeng Li,
  Director
• David Mark Slager,
  Director
• Harold Jacob,
  Director
• Gerald M Ostrov,
  Director
• Capital Management Lp Regals,
  10% owner
• Ronald Edward Law,
  Chief Strategy Officer
• Michael Berelowitz,
  Director
• Yifat Hen Zommer,
  CFO, Treasurer and Secretary
• Hilla Eisenberg,
  CFO, Treasurer and Secretary
• David Silberman,
  Chief Financial Officer
• Mark Daniel Hasleton,
  VP Business Development
• Michael Rabinowitz,
  Chief Commercial Officer
• Chaime Orlev,
  CFO, TREASURER AND SECRETARY
• Benjamin Shapiro,
  Director
• Michael Rabinowitz,
  Chief Commercial Officer
• Netanel Derovan,
  Chief Legal Officer
• Yadin Rozov,
  Director
• Yehuda Reznick,
  Director